Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-36

  1. 254 Posts.
    lightbulb Created with Sketch. 14
    Agree. To invest in BIO - properly with eyes wide open, one has to believe in the science, but also the management (leadership, sales and marketing, industry relationships, observance of prudent fiscal best practice, measurements etc). Its not just solely about the science..... although the science with MSB is extraordinary and lets face it will be a game changer for the world and those suffering these terrible afflictions (present company included with acute LBP from disc degerative disease). At the end of the day, investing in BIO which is at the forefront of innovation is highly risky...... big risk can also mean big reward too!!! Shit, time to shake up the drug/pharma game I say!!!

    GLTAH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.83
Change
-0.035(1.88%)
Mkt cap ! $2.331B
Open High Low Value Volume
$1.88 $1.94 $1.82 $11.55M 6.216M

Buyers (Bids)

No. Vol. Price($)
2 40245 $1.83
 

Sellers (Offers)

Price($) Vol. No.
$1.84 25000 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.